What is GT Biopharma Inc. Common Stock's Market Cap?

GT Biopharma Inc. Common Stock's Market Cap is $236.4M, based on as-reported figures from SEC (XBRL) filings.

What is GT Biopharma Inc. Common Stock's Revenue (TTM)?

GT Biopharma Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is GT Biopharma Inc. Common Stock's Net Income (TTM)?

GT Biopharma Inc. Common Stock's Net Income (TTM) is -$4.8M, based on as-reported figures from SEC (XBRL) filings.

What is GT Biopharma Inc. Common Stock's Diluted EPS (TTM)?

GT Biopharma Inc. Common Stock's Diluted EPS (TTM) is -0.11, based on as-reported figures from SEC (XBRL) filings.

GT Biopharma Inc. Common Stock (GTBP) Financial Statements

GT Biopharma Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S80Y31

XNAS · usd

5.24▲ 5.00 (2074.07%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close0.24

Day's Range4.91 – 5.95

52-Week Range0.22 – 5.95

Volume86.2K

Avg Volume443.9K

Share Statistics

Shares Outstanding

Employees1

ExchangeXNAS

Listed2021-02-11

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about GT Biopharma Inc. Common Stock (GTBP)

What is GT Biopharma Inc. Common Stock's Market Cap?: GT Biopharma Inc. Common Stock's Market Cap is $236.4M, based on as-reported figures from SEC (XBRL) filings.
What is GT Biopharma Inc. Common Stock's Revenue (TTM)?: GT Biopharma Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is GT Biopharma Inc. Common Stock's Net Income (TTM)?: GT Biopharma Inc. Common Stock's Net Income (TTM) is -$4.8M, based on as-reported figures from SEC (XBRL) filings.
What is GT Biopharma Inc. Common Stock's Diluted EPS (TTM)?: GT Biopharma Inc. Common Stock's Diluted EPS (TTM) is -0.11, based on as-reported figures from SEC (XBRL) filings.